Business & Tech
Dold Talks Medical Research with Marathon Pharmaceuticals Employees
The congressman was in Northbrook on Wednesday to talk about his support for the 21st Century Cures Act.
Illinois 10th District U.S. Congressman Robert Dold, R-Kenilworth met with employees at Marathon Pharmaceuticals in Northbrook on Wednesday to discuss “their shared commitment to research and development that can bring new rare disease treatments to the patients who need them,” according to a news release.
Dold discussed his support for the 21st Century Cures Act, a House-approved measure that aims to increase the number of drugs approved to treat rare diseases and provides a significant increase in funding for the National Institutes of Health (NIH).
Find out what's happening in Northbrookfor free with the latest updates from Patch.
“There are currently 10,000 known diseases, and sadly, we have cures for only 500,”said Dold. “There is no doubt that the United States has the best researchers and scientists in the world and the rigors and expense of drug development can delay approval of desperately needed new drugs. That’s one of the many reasons I have championed the bipartisan 21st Century Cures Act, which will increase funding for medical research and streamline regulatory processes. Together we can find new cures and change the lives of patients living with devastating diseases.”
Marathon is one of the pharmaceutical companies working to bring the promise of medical innovation to patients with unmet medical needs, according to the release. The company “works closely with researchers and patient advocates to develop new treatments for rare neurological and movement disorders. The company is developing a pipeline of rare disease treatments including a potential treatment for children with Duchenne muscular dystrophy.”
Find out what's happening in Northbrookfor free with the latest updates from Patch.
“Rep. Dold has long been a champion for medical research and innovation, and his efforts have helped the private sector bring hope to patients with unmet medical needs,” said Jeff Aronin, CEO of Marathon Pharmaceuticals. “We were honored to be able to meet with Congressman Dold today and discuss how government and industry can work together to improve patients’ lives.”
Photos by Greg Rothstein
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
